Reframing Atherosclerotic Cardiovascular Risk: The Case For Novel Risk Markers, June 25, 2021

Reframing Atherosclerotic Cardiovascular Risk: The Case for Novel Risk Markers, June 25, 2021

Cardiology University of Washington

Cardiovascular biomarkers of atherosclerotic risk

Mayo Clinic Laboratories

Novel and Emerging Biomarkers for Cardiovascular Risk Stratification: Role of Inflammatory and Other

BP International

Novel Markers of Cardiovascular Risk in Childhood Obesity

BP International

Introducing Dr. Jeff Keenan

University of Washington Medicine Heart Institute

How to Gauge 10-Year Atherosclerotic CVD Risk for Patients

Pharmacy Times TV

Beyond LDL: Assessing and Treating Residual ASCVD Risk | Marc-Andre Cornier, MD

University of Colorado | Department of Medicine

Cardiology Countdown | Biomarkers and Novel Anticoagulants by CHADS2 Risk Score

American College of Cardiology

Cardiovascular Risk in Oncologic Patients: One Calculator Does Not Fit All

Cardiology University of Washington

Marc Penn MD, PhD FACC, Novel Biomarkers for Risk Stratifying Patients for Cardiovascular Risk

Cleveland HeartLab

New research highlights potential cardiovascular risk of novel anti-osteoporotic drug

Patching Up Cardiovascular Risk

Novel CV Risk Markers by Prof Dr. Sarma Rachakonda

Prof Dr Sarma Rachakonda

Importance of Multi-Marker Approach for Defining Cardiovascular Risk

Fleetwood Onsite

Caffeinated Chest Cases # 002

Future-Rad - eLearning for radiologists

Cardi-OH ECHO - Methods for Assessing Cardiovascular Risk

Novel Tools to Enhance Risk Prediction of Cardiovascular Disease

Children's National Hospital

Caffeinated Chest Cases #001

Future-Rad - eLearning for radiologists